Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis

JAMA. 2021 Oct 19;326(15):1535. doi: 10.1001/jama.2021.13863.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • Glucocorticoids*
  • Humans
  • Remission Induction
  • Rituximab

Substances

  • Glucocorticoids
  • Rituximab